Bruker BioSciences Announces Agreement to Acquire the Bruker BioSpin for $914 Million in Cash and Stock

News   Dec 03, 2007

 
Bruker BioSciences Announces Agreement to Acquire the Bruker BioSpin for $914 Million in Cash and Stock
 
 
 

RELATED ARTICLES

Source of a Potent Greenhouse Gas Identified

News

A study of a Lake Erie wetland suggests that scientists have vastly underestimated the number of places methane-producing microbes can survive—and, as a result, today’s global climate models may be misjudging the amount of methane being released into the atmosphere.

READ MORE

Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell Types

News

New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.

READ MORE

New Cell-weighing Technique Helps Predict How Drugs Affect Cancer Cells

News

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE